FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

Comments Sought on eSubmissions for CDRH Product Complaints

Federal Register notice: FDA seeks comments on an information collection entitled Electronic Submission Process for Voluntary Allegations to the Cente...

Human Drugs

Orphan Status for Epygenix Epilepsy Drug

FDA grants Epygenix Therapeutics an Orphan Drug Designation for EPX-300 for treating patients with Dravet Syndrome, a lifelong form of epilepsy.

Human Drugs

FDA Gives Perrigo Final Approval on OTC Nexium Copy

FDA grants Perrigo final approval for its over-the-counter equivalent of AstraZenecas Nexium 24-hour (esomeprazole magnesium) capsules, indicated for ...

Human Drugs

FDA Approves Adamas Gocovri for Parkinsons Dyskinesia

FDA approves Adamas Pharmaceuticals Gocovri, the only approved drug indicated to treat dyskinesia in Parkinsons patients receiving levodopa-based ther...

Human Drugs

FDA Can Share Trade Secrets with EU, EMA

The European Medicines Agency says that a new confidentiality commitment will allow FDA to share confidential commercial information including trade s...

Medical Devices

Exempt OTC Denture Repair Kits from 510(k) Requirements: Petition

Hyman, Phelps & McNamara asks FDA to add OTC denture repair kits to the list of oral care products exempted from 510(k) premarket notification require...

Animal Drugs

Companion Animal Oncology Drug Guidance

FDA issues a guidance with recommendations for sponsors of investigational oncology drugs used in companion animals.

Animal Drugs

Veterinary Drug Human Food Residue Guidance

FDA issues an internationally harmonized guidance on the nature and types of data that can be useful in determining a toxicological acute reference do...

Medical Devices

FDA Clears RevMedx Gun/Knife Wound Device

FDA clears a RevMedx 510(k) for the XSTAT 12 and XSTAT 30 hemostatic devices for controlling severe, life-threatening bleeding from narrow entrance ex...

Human Drugs

Lilly CEO Expects Trump Drug Price Order

Eli Lilly CEO David Ricks says he expects an executive order on lowering drug prices by years end.